Elsevier, Transportation Research Procedia, Volume 60, 2022
The COVID-19 pandemic has devastated communities throughout the world. However, the negative impacts of another pandemic, affecting cities worldwide, arguably rival those of COVID. This destructive global health problem, which we have largely ignored, has been described as the “hurry virus” – the culture of speed that dominates modern lives and cities, causing us to constantly strive to ‘go faster’. This hurry virus has comprehensively infected our city transport systems from the early 20th century.
Elsevier, Journal of Adolescent Health, Volume , 2022
Purpose: The contribution of air pollution to subclinical atherosclerosis in a young population remains limited. This study aimed to assess whether long-term exposure to urban air pollutants increases carotid intima-media thickness (CIMT) in adolescents and young adults. Methods: This study included 789 subjects between the ages of 12 and 30 years who lived in the Taipei metropolis from a cohort of young Taiwanese individuals.
Elsevier, The Lancet Planetary Health, Volume 6, January 2022
Background: Combustion-related nitrogen dioxide (NO2) air pollution is associated with paediatric asthma incidence. We aimed to estimate global surface NO2 concentrations consistent with the Global Burden of Disease study for 1990–2019 at a 1 km resolution, and the concentrations and attributable paediatric asthma incidence trends in 13 189 cities from 2000 to 2019.
Background: Effectiveness of health programmes can be undermined when the implementation misaligns with local beliefs and behaviours. To design context-driven implementation strategies, we explored beliefs and behaviours regarding chronic respiratory disease (CRD) in diverse low-resource settings. Methods: This observational mixed-method study was conducted in Africa (Uganda), Asia (Kyrgyzstan and Vietnam) and Europe (rural Greece and a Roma camp). We systematically mapped beliefs and behaviours using the SETTING-tool.
Elsevier, The Lancet Regional Health - Western Pacific, Volume 18, January 2022
Background: Hepatitis C elimination may be possible with broad uptake of direct-acting antiviral treatments (DAAs). In 2016 the Australian government committed A$1.2 billion for five years of unlimited DAAs (March 2016 to February 2021) in a risk-sharing agreement with pharmaceutical companies. We assess the impact, cost-effectiveness and net economic benefits likely to be realised from this investment.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring novel and advanced personalized medicine approaches to tailor depression treatments.
Elsevier,
Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders, Second Edition, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by providing a framework for understanding neurodevelopment, explore the detection and diagnosis of developmental disabilities, describe techniques for investigation of the mechanisms of these disorders, and present principles of management.
